Physician

Ahmad Khan, M.D.

According to 2025 Medicare claims, Ahmad Khan, M.D. (NPI: 1922482892) practices gastroenterology in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Orange, FL. This provider's primary affiliated billing organization is FLORIDA HOSPITAL MEDICAL GROUP INC (NPI: 1225034234; TIN: 593214635) and primary practice location at 32827-7665.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 66 traditional Medicare patients, billed 163 HCPCS/CPT codes, and received $15,430 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 121 prescription claims across 68 beneficiaries totaling $10,944 in drug costs, led by Gavilyte-G (Peg3350/Sod Sulf,bicarb,cl/Kcl). 2021 DME data shows 52 claims. Open Payments data shows 8 records totaling $160. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $25,556 to $15,430. Similarly, Part D prescription costs have fallen sharply in recent years, from $703 to $10,944. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	173	405	$25,556
2019	430	1,089	$67,919
2020	249	626	$42,560
2021	85	329	$22,130
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	66	163	$15,430

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	12	29	$703
2016	70	366	$20,401
2017	78	697	$42,053
2018	66	524	$30,154
2019	24	51	$1,668
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	11	26	$11,386
2023	15	50	$19,479
2024	68	121	$10,944

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	36	$1,726
2021	N/R	52	$2,473
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	45	45	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	17	19	$99
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	12	25	$93
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	17	17	$83
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	25	26	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	34	36	$518
Pantoprazole Sodium	Pantoprazole Sodium	31	1,620	$293

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$160	Takeda Pharmaceuticals U.S.A., Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmad Khan, M.D.?

Tedicare shows public-source Medicare data for Ahmad Khan, M.D. (NPI 1922482892), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmad Khan, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ahmad Khan, M.D.?

Ahmad Khan, M.D. is linked to FLORIDA HOSPITAL MEDICAL GROUP INC (billing NPI 1225034234) in the available physician profile data.

Does Ahmad Khan, M.D. have Open Payments data?

Ahmad Khan, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.